Print Page   |   Contact Us
Community Search

Online CME: Physician Wellness

Online CME: Psychiatric Practice During COVID-19

9/25/2020 » 9/27/2020
Fall 2020 CME Meeting & EXPO

News & Press: News Relating to Practice

FREE Webinar December 13, 2017, 12:00pm – 1:00pm EST

Monday, December 11, 2017  
Share |

Earn Up to 1 hour of CME!
The Role of Long-Acting Antipsychotics in the Management of Schizophrenia
December 13, 2017, 12:00pm – 1:00pm EST
The presentation will provide information about the problem of relapses for outcomes in people with schizophrenia, discussing the potential role and value of long-acting-injectable antipsychotics in the management of schizophrenia. Reasons for relapse and for failing to achieve remission and recovery will be outlined, including the relevance and frequency of non-adherence. Characteristics of different long-acting-injectable antipsychotics will be compared. Studies and meta-analyses comparing long-acting-injectable antipsychotics vs placebo and vs oral antipsychotics across different study designs will be critically reviewed. Adverse effects of long-acting-injectable antipsychotics and their potential for use early during the illness course will be examined. Finally, arguments for and against long-acting-injectable antipsychotics as well as ways to effectively present and offer long-acting-injectable antipsychotics to patients with schizophrenia will be described.
Speaker: Christoph Correll, MD
Christoph Correll is Professor of Psychiatry at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA, and head of the department of child and adolescent psychiatry at the Charité University, Berlin, Germany. He is both a board-certified general psychiatrist, and child and adolescent psychiatrist. Professor Correll’s research and clinical work focus on the identification, characterization, and treatment of adults and youth with severe psychiatric disorders, including psychotic and mood disorders, as well as the interface between mental and physical illness. He further focuses on psychopharmacology and comparative effectiveness. Professor Correll has authored over 500 journal articles and has received over 30 awards and fellowships for his work. Since 2014, the year of inception of this metric, he has been listed each year by Thomson Reuters in as one of “the most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”.
Register here:
CME Credit provided by AKH, Inc., Advancing Knowledge in Healthcare.
This activity has been approved for AMA PRA Category 1 Credit™.
See final CME activity announcement for specific details.
If you have any questions, please e-mail
If you have any technical questions or problems, please e-mail

Sign In

Classified Ads